Early anemia of premature newborns: optimization of therapeutic strategies

Демихов, В. Г.; Дмитриев, А. В.; Шокер, О. А.; Demikhova, E.V.

doi:10.17650/2311-1267-2015-1-81-87

Cited by 1 publication

(1 citation statement)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Ранняя схема подразумевает начало терапии рчЭПО до 8 суток жизни, поздняя -после 8 суток жизни. При применении рчЭПО отмечается повышение ретикулоцитов, концентрации гематокрита и маркеров потребления железа, которое проявляется снижением уровня ферритина [33].…”

Section: сравнительный анализ частоты заболеваний при различных способах профилактики и лечения ран у исследуемых групп пациентовunclassified

The effectiveness of umbilical cord milking/ delayed cord clamping and recombinant human erythropoietin in reducing red blood cell transfusions in extremely and very low birth weight infants

Шарафутдинова

Balashova

Kirtbaya

et al. 2021

Voprosy gematologii/onkologii i immunopatologii v pediatrii

View full text Add to dashboard Cite

Anemia of prematurity is one of the most common and serious problems of neonatology. The main focus is to prevent of anemia in preterm infants. The aim of the study was to assess effectiveness of umbilical cord milking/delayed cord clamping and erythropoietin therapy in reducing red blood cell transfusions in extremely and very low birth weight infants. This clinical study was approved by the Commission on ethics of biomedical research (Protocol No. 12 November 17, 2016) and approved by the Scientific Council of National Medical Research Center for obstetrics, gynecology and perinatology named academician V.I. Kulakov of the ministry of Healthcare of the Russian Federation (Protocol No. 19 of November 29, 2016). Analysis of 482 extremely and very low birth weight infants was conducted (from 2008 to 2018). Umbilical cord milking or delayed umbilical cord clamping, both, and in combination with recombinant human erythropoietin therapy, decreasing the phlebotomy losses significantly reduces the need for transfusions of red blood cells in extremely and very low birth weight infants. The effectiveness of erythropoietin therapy, time of its start and various treatment schemes remain controversial, therefore further researches are necessary.

show abstract

The effectiveness of umbilical cord milking/ delayed cord clamping and recombinant human erythropoietin in reducing red blood cell transfusions in extremely and very low birth weight infants

Шарафутдинова

Balashova

Kirtbaya

et al. 2021

Voprosy gematologii/onkologii i immunopatologii v pediatrii

View full text Add to dashboard Cite

show abstract

Early anemia of premature newborns: optimization of therapeutic strategies

Cited by 1 publication

References 16 publications

The effectiveness of umbilical cord milking/ delayed cord clamping and recombinant human erythropoietin in reducing red blood cell transfusions in extremely and very low birth weight infants

The effectiveness of umbilical cord milking/ delayed cord clamping and recombinant human erythropoietin in reducing red blood cell transfusions in extremely and very low birth weight infants

Contact Info

Product

Resources

About